The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Apr. 13, 2021
Applicant:

Affyimmune Therapeutics, Inc., Natick, MA (US);

Inventors:

Huan Yang, Millbury, MA (US);

Moonsoo Jin, New York, NY (US);

Janusz Puc, Sudbury, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C07K 16/30 (2006.01); C07K 14/725 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); C12N 5/10 (2006.01); C07K 16/46 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 39/001166 (2018.08); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C07K 16/30 (2013.01); C07K 16/46 (2013.01); C12N 5/10 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/03 (2013.01);
Abstract

The present invention provides EpCAM antibodies with different affinities. The present invention also provides chimeric antigen receptors (CARs) specific to EpCAM. CAR T cells comprising human EpCAM scFv having a low and sufficient affinity to EpCAM can avoid targeting healthy tissues with low EpCAM expression while exhibiting long-term efficacy against tumor tissues with high EpCAM expression. The present invention also relates to an adoptive cell therapy method for treating cancer by administering the CAR-T cells comprising human EpCAM scFv to a subject suffering from cancer, whereby the CAR T cells bind to the cancer cells overexpressing EpCAM and kill the cancer cells.


Find Patent Forward Citations

Loading…